Industry News
Research training centre for portable sample analysis
The Australian Research Council has opened its latest research training centre, the ARC Industrial Transformation Training Centre for Portable Analytical Separation Technologies (ASTech), at the University of Tasmania.
[ + ]Collaboration bridges the gap
As part of the announcement of their new Asia Pacific Innovation Centre, Johnson & Johnson - parent company of Janssen - will facilitate new collaborations with Australian university researchers.
[ + ]Prime Minister's Prizes for Science 2014
The accomplishments of Australian scientists and science educators have been celebrated with the announcmement of this year's Prime Minister's Prizes for Science.
[ + ]Feedback invited on boosting commercial returns
The government is seeking input from the research sector and industry on its strategy to boost commercial returns from research. [ + ]
Patrys names Roger McPherson interim CEO
Patrys (ASX:PAB) has appointed an interim CEO to ensure an orderly transition once it chooses a permanent replacement for outgoing chief Dr Marie Roskrow.
[ + ]VivaGel condoms on sale at Woolworths: Starpharma
Starpharma (ASX:SPL) is set to start reaping royalties from partner Ansell's sales of VivaGel coated condoms and has received a $4.2m R&D tax incentive rebate for FY14.
[ + ]Targeting cancer's sweet tooth
The different way in which cancer cells metabolise sugar compared to normal cells is the focus of a clinical trial due to start early next year. [ + ]
Qiagen and Astellas Pharma to develop companion diagnostics
Sample and assay technology company Qiagen has announced a collaboration agreement with Astellas Pharma to develop and commercialise companion diagnostics paired with Astellas drugs for use in cancer and other diseases. [ + ]
Federal government announces Expert Review of Medicines and Medical Devices Regulation
Further to the recent launch of the Industry Innovation and Competitiveness Agenda, the federal government has announced the establishment of an independent panel to undertake a review of medicines and medical devices regulation in Australia.
[ + ]Antisense paves way for IND for MS drug
Antisense Therapeutics (ASX:ANP) has received positive feedback from the US FDA on plans to conduct an IND-enabling phase IIb trial of MS drug candidate ATL1102.
[ + ]Collaboration to measure metabolism of 3D microtissue
The US-based Seahorse Bioscience and Moffitt Cancer Center have received an SBIR contract, through the National Cancer Institute, to develop a reproducible method that will enable the measurement of metabolism of 3D microtissue. [ + ]
BioMeter shows re-emergence of late-stage biotech deals
Law firm Morrison & Foerster (MoFo) has released its Q3 edition of BioMeter. The quarterly report measures the health of the biotech industry. [ + ]
AusBiotech 2014 kicks off on Wednesday
The AusBiotech national conference will this week bring together the entire biotechnology 'ecosystem' to share ideas and progress their biotechnology development work.
[ + ]Sometimes a graph is just a graph
Researchers from the Cornell University Food and Brand Lab have found that graphs or formulas accompanying medical information can lead consumers to believe products are more effective, despite not actually providing additional evidence. [ + ]
No evidence of arthritis in Egyptian mummies
Researchers have disputed the claim that ancient Egyptian royal families suffered from the systemic disease ankylosing spondylitis, which causes inflammation of the spinal joints. [ + ]